You’re not alone: Fraser Valley West has a vibrant Crohn’s and colitis community, made up of people with inflammatory bowel disease, families, volunteers, and more. Together, we share experiences, raise funds at the Gutsy Walk and heighten awareness.

There are an estimated 4,000 people with Crohn’s disease or ulcerative colitis in the Fraser Valley West community. We understand the challenges you and your family may be facing – because we face them, too.
 
Gustsy Learning Series

Managing your mental health and IBD

The Gutsy Learning Series (GLS) offers a unique opportunity to learn directly from Canada’s leading experts in inflammatory bowel disease (IBD). Whether you're living with Crohn’s ...

 • 
Virtual - Online
 • 
Lady sitting on the couch with her daughter

Caregiver Peer Connect Event

Ready to connect with those who understand the challenges of being a caregiver to someone with Crohn's disease, ulcerative colitis, and other forms of inflammatory bowel disease (IBD)?   ...

 • 
Virtual
 • 
A young woman looking at her mobile device

Canada Wide Peer Connect Event

Ready to connect with those who understand the challenges of Crohn’s disease, ulcerative colitis, and other forms of inflammatory bowel disease (IBD)?  Join our upcoming Peer Connect event ...

 • 
Virtual
 • 
Gutsy Learning Sereies logo on background of a public speaker

New and emerging IBD therapies in Canada

Curious about the latest advances in Crohn’s disease and ulcerative colitis care? Join gastroenterologist Dr. Robert Battat and lived experience speaker Sophie Dufresne as they break down new ...

 • 
Virtual - Online
 • 

Facebook

More on Facebook
 
Remember to bookmark this page.

News

“You don’t need to be superhuman”: How a small-town hockey player made it to the NCAA in the face of Crohn’s disease

“You don’t need to be superhuman”: How a small-town hockey player made it to the NCAA in the face of Crohn’s disease

Takeda Canada announces positive results for ENTYVIO® (vedolizumab) vs. Humira® (adalimumab) in first IBD study to compare biological agents head-to-head

Takeda Canada announces positive results for ENTYVIO® (vedolizumab) vs. Humira® (adalimumab) in first IBD study to compare biological agents head-to-head

 45 46 47 48 49 50 51 52 53 54